Hermelin, Chairman of the Board and Chief Executive Officer stated, "KV enjoyed a solid third quarter, including growth at ETHEX due to continued revenue contribution from the 100 mg and 200 mg strengths of Metoprolol Succinate Extended Release Tablets and our Diltiazem HCl
Extended- Release Capsules.
Chronic oral administration of diltiazem HCl
to patients in doses up to 540 mg/day has resulted in small increases in PR interval, and on occasion produces abnormal prolongation.
The Company expects increased contribution from both Diltiazem HCl
Extended Release Capsules and its two strengths of Metoprolol Succinate Extended Release Tablets for the remainder of fiscal 2008 and beyond.
Food and Drug Administration (FDA) has approved Cardizem(R) LA, a new graded extended-release formulation of diltiazem HCl
for the treatment of high blood pressure or hypertension.
Biovail Corporation (NYSE:BVF) (TSE:BVF) today announced that it has received approval from the Food and Drug Administration for its New Drug Application of a novel once daily controlled release formulation of Diltiazem Hcl
The company broadened its product base during the year with the FDA approvals of acyclovir injection for the treatment of herpes simplex and diltiazem HCL
injection for the treatment of irregular heartbeats.
During the third quarter, Meridian also received FDA approval of diltiazem HCl
injection, a generic injectable drug for the treatment of irregular heartbeats (arrhythmias).
Food and Drug Administration (FDA) for diltiazem HCl
injection, a generic injectable drug for the treatment of heart disease.
This launch is the first part of an alliance in which Taylor and Baxter will jointly develop, manufacture and market four injectable products with current sales in excess of $200 million: Ketorolac Tromethamine Injection, Amrinone Lactate Injection, Diltiazem HCl
Injection and Labetalol HCl Injection.